Diabetes mellitus. Diabetes mellitus due to underlying condition
Conditions
Interventions
Intervention 1: In this study, 42 patients were selected and divided into two groups of control and case, each group of 21 people.In this study, the allocation of samples to the study groups will be s
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 64 Years
Inclusion criteria
Inclusion criteria: The patient's desire to enter the study Age between 30-64 years, whose definitive diagnosis of diabetes has been made by performing two FBS tests more than 126 and the approval of the relevant specialist. Patients with a history of type 2 diabetes are diagnosed less than two years after the onset of the disease and use at least one standard oral medication (metformin tablets) for initial control of the disease. HbA1c is more equal to 8% and less than 9%.
Exclusion criteria
Exclusion criteria: blood sugar more than 300 and HbA1c is more equal to 9% . Have indications for starting insulin and other injectable therapy. Patients treated with insulin Moderate to severe renal insufficiency (GFR less than 45 or albuminuria more than 300 mg) Liver failure (diagnosis by an internal medicine specialist or gastroenterologist based on bilirubin, albumin and liver enzymes) Class 3 and 4 heart failure Diabetic retinopathy Serious medical illness Simultaneous infectious diseases including pulmonary tuberculosis, diabetic foot ulcers and ... High blood pressure (systolic above 160 or diastolic above 100 mm Hg) or need to take more than three antihypertensive drugs Women who decide to get pregnant Pregnant women and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FBS. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: Calorimetric by enzymatic method.;Two-hour blood sugar. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: Calorimetric by enzymatic method.;HbA?C. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: chromatography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood serum cholesterol level of patients. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: Calorimetric by enzymatic method.;Blood serum triglyceride level of patients. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: Calorimetric by enzymatic method.;Blood serum LDL cholesterol level of patients. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: Calorimetric by enzymatic method.;Blood serum HDL cholesterol level of patients. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: Calorimetric by enzymatic method.;Systolic blood pressure. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: Blood pressure device.;Diastolic blood pressure. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: Blood pressure device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Kolangi
Gorgan University of Medical Sciences
Outcome results
None listed